bioRxiv / medRxiv
open access
CC BY 4.0
Multi-Omic Profiling Reveals Antibody-Drug Conjugate Targetability in Ovarian Cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Systems serology of responses against tumor antigens in ovarian cancer reveal disrupted Fc-mediated immunity#234314
- Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer#898491
- Immunohistochemical and molecular studies on ovarian cancer progression and prognosis#1015879
- Proteomic profiling and molecular reclassification of high-grade serous ovarian cancer identifies prognostic subtypes and immunotherapy biomarkers.#125390
- Supplementary file 1_Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.docx#300638
Record · ID 133222
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive